You can find the annual or quarterly income statement of Mira Pharmaceuticals Inc here for insights into the performance and operational efficiency of Mira Pharmaceuticals Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q1

FY2021Q1

Total revenue

--0.00

Revenue

--0.00

Operating expenses

-36.73%1.32M

-10.67%1.55M

2.09%1.81M

-20.24%2.44M

-34.13%2.08M

78.38%1.73M

32.01%1.77M

--3.06M

--3.16M

--970.22K

-8.96%1.34M

2726.27%1.47M

--52.05K

R&D expenses

-61.34%412.64K

-19.25%496.20K

-58.75%314.40K

122.52%861.44K

5.14%1.07M

708.26%614.46K

180.66%762.28K

--387.12K

--1.02M

---101.02K

-43.30%271.61K

1321.22%479.05K

--33.71K

Operating profit

36.73%-1.32M

10.67%-1.55M

-2.09%-1.81M

20.24%-2.44M

34.13%-2.08M

-78.38%-1.73M

-32.01%-1.77M

---3.06M

---3.16M

---970.22K

8.96%-1.34M

-2726.27%-1.47M

---52.05K

Net non-operating interest income (expenses)

Non-operating interest income

--15.70K

--8.49K

--21.42K

----

Non-operating interest expense

----

--2.73M

--427.73K

--295.89K

-57.20%1.65K

-21.52%3.86K

--4.92K

Special income (expenses)

--176.06K

----

Other non-operating income (expenses)

---12.44K

---107.00

----

Income before tax

44.34%-1.14M

9.08%-1.54M

-3.84%-1.78M

58.54%-2.40M

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

---5.79M

---3.59M

---1.27M

9.08%-1.34M

-2488.94%-1.48M

---56.98K

Income after tax

44.34%-1.14M

9.08%-1.54M

-3.84%-1.78M

58.54%-2.40M

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

---5.79M

---3.59M

---1.27M

9.08%-1.34M

-2488.94%-1.48M

---56.98K

Net income from continuous operations

44.34%-1.14M

9.08%-1.54M

-3.84%-1.78M

58.54%-2.40M

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

---5.79M

---3.59M

---1.27M

9.08%-1.34M

-2488.94%-1.48M

---56.98K

Net income attributable to controlling interests

-1010.37%-22.69M

9.08%-1.54M

-3.84%-1.78M

58.54%-2.40M

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

---5.79M

---3.59M

---1.27M

9.08%-1.34M

-2488.94%-1.48M

---56.98K

Preferred share dividend

--21.56M

----

Net income attributable to common shareholders

-1010.37%-22.69M

9.08%-1.54M

-3.84%-1.78M

58.54%-2.40M

43.03%-2.04M

-33.58%-1.69M

-28.09%-1.72M

---5.79M

---3.59M

---1.27M

9.08%-1.34M

-2488.94%-1.48M

---56.98K

Basic earnings per share

-768.23%-1.18

20.89%-0.09

-22.96%-0.11

62.99%-0.14

48.45%-0.14

-33.26%-0.11

4.17%-0.09

---0.39

---0.26

---0.09

9.09%-0.09

-2491.71%-0.10

--0.00

Diluted earnings per share

-768.23%-1.18

20.89%-0.09

-22.96%-0.11

62.99%-0.14

48.45%-0.14

-33.26%-0.11

4.17%-0.09

---0.39

---0.26

---0.09

9.09%-0.09

-2491.71%-0.10

--0.00

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

